Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Bryan S Squires"'
Autor:
Ronald Levitin, MD, Kamran Salari, MD, Bryan S. Squires, MD, Allison J. Hazy, MD, Michael J. Maywood, MD, Patrick Thrasher, BS, Anthony P. Delise, MD, Muayad F. Almahariq, MD, PhD, Nayana Dekhne, MD, Lauren Oliver, DO, Peter Y. Chen, MD, Kailee J. Walters, MS, Diane Dudley, BS, RT, Joshua T. Dilworth, MD, PhD
Publikováno v:
Advances in Radiation Oncology, Vol 8, Iss 6, Pp 101283- (2023)
Purpose: Postmastectomy radiation therapy (PMRT) reduces disease recurrence in appropriately selected patients but may compromise implant-based reconstruction. We investigated whether near-surface dose correlates with radiation-related toxic effects
Externí odkaz:
https://doaj.org/article/1f3be4ae8ca241f18c91ac778cf90669
Publikováno v:
International Journal of Clinical Oncology. 26:2282-2294
Uterine carcinosarcoma (UCS) confers a high recurrence risk following surgery, and adjuvant chemotherapy (CHT) is typically administered in all stages. The benefit of radiation therapy (RT) in UCS, when added to adjuvant CHT, is unknown. We sought to
Autor:
Charles J Touchette, Shibin Sun, Huai-Che Yang, Douglas Kondziolka, Ahmet Atik, Cheng-Chia Lee, Nasser Mohammed, Roman Liscak, J.C. Shiao, Jaromir Hanuska, Kathryn N. Kearns, Dale Ding, Mehran Yusuf, Zhiyuan Xu, L. Dade Lunsford, Jason P. Sheehan, Inga S. Grills, Yi-Chieh Hung, Brian J. Williams, Bryan S Squires, David Mathieu, Shiao Y. Woo
Publikováno v:
Journal of Neurosurgery. :1-10
OBJECTIVECentral neurocytomas (CNs) are uncommon intraventricular tumors, and their rarity renders the risk-to-benefit profile of stereotactic radiosurgery (SRS) unknown. The aim of this multicenter, retrospective cohort study was to evaluate the out
Autor:
Ricky E Olson, M.D. Johnson, Inga S. Grills, Peter Y. Chen, K. Meyer, Zaid A. Siddiqui, Andrew M. Baschnagel, Bryan S. Squires, Daniel J. Krauss
Publikováno v:
Neurooncol Pract
Background The long-term risk of necrosis after radiosurgery for brain metastases is uncertain. We aimed to investigate incidence and predictors of radiation necrosis for individuals with more than 1 year of survival after radiosurgery for brain meta
Autor:
N. Sebastian, Aleksander Vayntraub, Rohan Deryaniyagala, Janice M. Mehnert, Thomas J. Quinn, Nadine Tayeb, Quais N. Hassan, Bryan S. Squires
Publikováno v:
Cureus
Purpose/objective(s) Merkel cell carcinoma (MCC) is a rare, aggressive cutaneous neoplasm traditionally managed with surgical resection followed by radiotherapy (RT). With the recent approval of checkpoint inhibitors, chemotherapy is less commonly ut
Autor:
Bryan S. Squires, Peyman Kabolizadeh, Jacob S Parzen, Thomas J. Quinn, Muayad F. Almahariq, Aleksander Vayntraub, Andrew B. Thompson, John M. Robertson
Publikováno v:
J Gastrointest Oncol
Background The optimal management of patients with stage I-II squamous cell carcinoma (SCC) of the anus is controversial. The current study evaluates the efficacy of combined chemotherapy and radiation therapy (CRT) versus radiation therapy (RT) alon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d20832cc46fb6fe761c1c71c3fc5e24e
https://europepmc.org/articles/PMC8107581/
https://europepmc.org/articles/PMC8107581/
Publikováno v:
Cureus
Hidradenocarcinomas are rare malignant sweat gland tumors that typically arise in the head and neck area. To the best of our knowledge, this is the only reported instance of hidradenocarcinoma of the abdominal wall as well as the first case arising f
Publikováno v:
International journal of clinical oncology. 26(12)
Uterine carcinosarcoma (UCS) confers a high recurrence risk following surgery, and adjuvant chemotherapy (CHT) is typically administered in all stages. The benefit of radiation therapy (RT) in UCS, when added to adjuvant CHT, is unknown. We sought to
Autor:
Lauren Andring, Inga S. Grills, Zachary A. Seymour, Jeffrey Jacob, K. Marvin, Bryan S. Squires, Daniel K. Fahim, Hong Ye
Publikováno v:
The International journal of neuroscience.
OBJECTIVES Limited data exist regarding radionecrosis (RN) rates when patients receive immunotherapy (IT) and SRS for brain metastases. This study assesses the influence of such treatments on the rate of RN. METHODS We retrospectively reviewed 352 le
Autor:
Bryan S. Squires, J Fontanesi, Craig W. Stevens, Thomas Guerrero, Inga S. Grills, Thomas J. Quinn, K.C. Lee
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 111:e464
Purpose/objective(s) Stereotactic body radiotherapy (SBRT) is standard for early-stage non-small cell lung cancer in patients who are inoperable or refuse surgery. Data are limited regarding definitive hypofractionated radiotherapy (HFRT) regimens fo